127 related articles for article (PubMed ID: 8890843)
1. Prevalence of hepatitis G virus in Queensland blood donors.
Moaven LD; Hyland CA; Young IF; Bowden DS; McCaw R; Mison L; Locarnini SA
Med J Aust; 1996 Oct; 165(7):369-71. PubMed ID: 8890843
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis G virus RNA in French blood donors and recipients.
Loiseau P; Mariotti M; Corbi C; Ravera N; Girot R; Thauvin M; Portelette E; Mariette X; Roudot-Thoraval F; Benbunan M; Lefrère JJ
Transfusion; 1997 Jun; 37(6):645-50. PubMed ID: 9191827
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components.
Hitzler WE; Runkel S
Clin Lab; 2004; 50(1-2):25-31. PubMed ID: 15000218
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis G virus infection in screened Chinese blood donors.
Ren FR; Wang Y; Li H; Chen HS; Zhao HY
Vox Sang; 1998; 74(1):51-2. PubMed ID: 9481862
[TBL] [Abstract][Full Text] [Related]
5. Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan.
Yoshikawa A; Fukuda S; Itoh K; Kosaki N; Suzuki T; Hirakawa K; Nakao H; Inoue T; Fukuda M; Okamoto H
Transfusion; 1997 Jun; 37(6):657-63. PubMed ID: 9191829
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
Zehender G; De Maddalena C; Bosisio AB; Gianotto M; Santambrogio S; Moroni M; Galli M
J Hum Virol; 1998; 1(2):96-100. PubMed ID: 10195238
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis G virus in the general population and in patients on hemodialysis.
Hayashi J; Furusyo N; Sawayama Y; Kishihara Y; Kawakami Y; Ariyama I; Etoh Y; Kashiwagi S
Dig Dis Sci; 1998 Sep; 43(9):2143-8. PubMed ID: 9753284
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia.
Poovorawan Y; Theamboonlers A; Chongsrisawat V; Seksarn P; Jarvis L; Simmonds P
J Gastroenterol Hepatol; 1998 Mar; 13(3):253-6. PubMed ID: 9570237
[TBL] [Abstract][Full Text] [Related]
10. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis G virus (HGV) infection in voluntary and commercial blood donors in India.
Kar P; Bedi P; Berry N; Chakravorty A; Gupta RK; Saha R; Das BC
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):7-10. PubMed ID: 11025177
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis G in patients on chronic hemodialysis.
Matzkies FK; Bahner U; Weizenegger M; Bartel J; Cullen P; Schaefer RM
Clin Lab; 2000; 46(5-6):247-50. PubMed ID: 10853231
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 among blood donors in Southeastern France.
Cantaloube JF; Gallian P; Biagini P; Attoui H; Escher J; Zappitelli JP; Delord Y; de Micco P; de Lamballerie X
Transfusion; 1999 Jan; 39(1):95-102. PubMed ID: 9920172
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors.
Nordbø SA; Krokstad S; Winge P; Skjeldestad FE; Dalen AB
J Clin Microbiol; 2000 Jul; 38(7):2584-90. PubMed ID: 10878048
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis G virus infection in acute fulminant hepatitis: prevalence of HGV infection and sequence analysis of a specific viral strain.
Sheng L; Soumillion A; Beckers N; Wu CG; Verslype C; Nevens F; Pirenne J; Aerts R; Kosala H; Fevery J; Yap SH
J Viral Hepat; 1998 Sep; 5(5):301-6. PubMed ID: 9795913
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology.
Sarrazin C; Herrmann G; Roth WK; Lee JH; Marx S; Zeuzem S
J Hepatol; 1997 Aug; 27(2):276-83. PubMed ID: 9288601
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis.
Ideura T; Tanaka E; Nakatsuji Y; Kobayashi M; Kanno Y; Oguchi H; Hora K
J Gastroenterol Hepatol; 1997 Nov; 12(11):762-5. PubMed ID: 9430044
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients.
Roth WK; Waschk D; Marx S; Tschauder S; Zeuzem S; Bialleck H; Weber H; Seifried E
Transfusion; 1997 Jun; 37(6):651-6. PubMed ID: 9191828
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of GBV-C/hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and hemodialysis patients in Egypt.
El-Zayadi AR; Abe K; Selim O; Naito H; Hess G; Ahdy A
J Virol Methods; 1999 Jun; 80(1):53-8. PubMed ID: 10403676
[TBL] [Abstract][Full Text] [Related]
20. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis.
Tanaka E; Kiyosawa K; Shimoda K; Hino K; Tacke M; Schmolke S; Engel AM; Hess G
J Viral Hepat; 1998 May; 5(3):153-9. PubMed ID: 9658367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
